Prostate carcinoma
|
0.050 |
AlteredExpression
|
disease |
BEFREE |
Caspase-7 is activated during lovastatin-induced apoptosis of the prostate cancer cell line LNCaP.
|
9426061 |
1998 |
Malignant neoplasm of prostate
|
0.040 |
AlteredExpression
|
disease |
BEFREE |
Caspase-7 is activated during lovastatin-induced apoptosis of the prostate cancer cell line LNCaP.
|
9426061 |
1998 |
Prostate carcinoma
|
0.050 |
Biomarker
|
disease |
BEFREE |
Thus, adenoviral-mediated transfer of caspase-7 may offer a new effective approach for the treatment of prostate cancer.
|
9927051 |
1999 |
Malignant neoplasm of prostate
|
0.040 |
Biomarker
|
disease |
BEFREE |
Thus, adenoviral-mediated transfer of caspase-7 may offer a new effective approach for the treatment of prostate cancer.
|
9927051 |
1999 |
Prostate carcinoma
|
0.050 |
Biomarker
|
disease |
BEFREE |
These results suggest that the mitochondrial pathway is involved in Fas-mediated apoptosis in prostatic carcinoma cell lines and that, in addition to caspase-7 and caspase-3, there are other factors that confer nuclear apoptotic activity.
|
10786680 |
2000 |
Prostate carcinoma
|
0.050 |
Biomarker
|
disease |
BEFREE |
Using adenoviral technology, we overexpressed the proapoptotic molecules pro-caspase-3, pro-caspase-7, and Bax to induce therapeutic apoptosis of prostate cancer cell lines growing in vitro and in vivo.
|
11196158 |
2001 |
Malignant neoplasm of prostate
|
0.040 |
Biomarker
|
disease |
BEFREE |
Using adenoviral technology, we overexpressed the proapoptotic molecules pro-caspase-3, pro-caspase-7, and Bax to induce therapeutic apoptosis of prostate cancer cell lines growing in vitro and in vivo.
|
11196158 |
2001 |
Malignant Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
This is the first report on the CASPASE-7 gene mutations in human malignancies, and our data suggest that the inactivating mutations of the CASPASE-7 gene might lead to the loss of its apoptotic function and contribute to the pathogenesis of some human solid cancers.
|
12970753 |
2003 |
Carcinoma
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Overall, we detected CASPASE-7 mutations in two of 98 colon carcinomas (2.0%), one of 50 esophageal carcinomas (2.0%) and one of 33 head/neck carcinomas (3.0%).
|
12970753 |
2003 |
Myocardial Reperfusion Injury
|
0.500 |
Biomarker
|
phenotype |
CTD_human |
Minocycline inhibits caspase activation and reactivation, increases the ratio of XIAP to smac/DIABLO, and reduces the mitochondrial leakage of cytochrome C and smac/DIABLO.
|
14998631 |
2004 |
melanoma
|
0.010 |
Biomarker
|
disease |
LHGDN |
Cisplatin-induced apoptosis in melanoma cells: role of caspase-3 and caspase-7 in Apaf-1 proteolytic cleavage and in execution of the degradative phases.
|
15033720 |
2003 |
Stomach Neoplasms
|
0.010 |
AlteredExpression
|
group |
LHGDN |
Loss of caspase-2, -6 and -7 expression in gastric cancers.
|
15511269 |
2004 |
Malignant neoplasm of breast
|
0.320 |
Biomarker
|
disease |
CTD_human |
Capsaicin-induced inactivation of sensory neurons promotes a more aggressive gene expression phenotype in breast cancer cells.
|
16583263 |
2006 |
Breast Carcinoma
|
0.310 |
Biomarker
|
disease |
CTD_human |
Capsaicin-induced inactivation of sensory neurons promotes a more aggressive gene expression phenotype in breast cancer cells.
|
16583263 |
2006 |
Mammary Neoplasms, Human
|
0.300 |
Biomarker
|
disease |
CTD_human |
Capsaicin-induced inactivation of sensory neurons promotes a more aggressive gene expression phenotype in breast cancer cells.
|
16583263 |
2006 |
Mammary Neoplasms
|
0.300 |
Biomarker
|
group |
CTD_human |
Capsaicin-induced inactivation of sensory neurons promotes a more aggressive gene expression phenotype in breast cancer cells.
|
16583263 |
2006 |
Mammary Carcinoma, Human
|
0.300 |
Biomarker
|
disease |
CTD_human |
Capsaicin-induced inactivation of sensory neurons promotes a more aggressive gene expression phenotype in breast cancer cells.
|
16583263 |
2006 |
Neoplasms
|
0.090 |
Biomarker
|
group |
BEFREE |
Consequently, trastuzumab decreased prosurvival/proliferative proteins: phospho-HER2/neu, total HER2/neu, phospho-Akt (protein kinase B), glycogen synthetase kinase-3, cyclin D1, and the antiapoptotic protein X chromosome-linked inhibitor of apoptosis, whereas increasing the proapoptotic protein, caspase-7, in raloxifene-treated MCF-7RALT tumors.
|
16609042 |
2006 |
Leukemia, Myelocytic, Acute
|
0.300 |
Biomarker
|
disease |
CTD_human |
Discovery of epigenetically silenced genes in acute myeloid leukemias.
|
17330099 |
2007 |
Acute Myeloid Leukemia, M1
|
0.300 |
Biomarker
|
disease |
CTD_human |
Discovery of epigenetically silenced genes in acute myeloid leukemias.
|
17330099 |
2007 |
Acute Myeloid Leukemia (AML-M2)
|
0.300 |
Biomarker
|
disease |
CTD_human |
Discovery of epigenetically silenced genes in acute myeloid leukemias.
|
17330099 |
2007 |
Neoplasm Metastasis
|
0.010 |
AlteredExpression
|
phenotype |
BEFREE |
An altered expression of growth- and metastasis-associated genes (LI-cadherin, CEACAM6, RAC1, AnnexinA1, thrombomodulin, epiregulin, S100A4, TP53, TP53BP, caspase-2, caspase-3, caspase-7, plakoglobin, and neuregulin-2) was also observed as a consequence of the silencing of MUC4.
|
17406026 |
2007 |
Rheumatoid Arthritis
|
0.020 |
Biomarker
|
disease |
BEFREE |
Our results support involvement of the CASP7 gene in the susceptibility to RA.
|
17504820 |
2007 |
Lymphoma
|
0.010 |
GeneticVariation
|
group |
LHGDN |
Absence of CASP7 and CASP8 mutation in gastrointestinal lymphomas.
|
17532763 |
2007 |
Glioblastoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Knockdown of GRP78 in glioblastoma cell lines induces CHOP and activates caspase-7 in temozolomide-treated cells.
|
17942911 |
2007 |